| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
GE KH MA MD TN |
| (30) |
Priority: |
27.11.2023 US 202363602704 P
|
| (71) |
Applicant: GlaxoSmithKline Intellectual Property Development
Limited |
|
Stevenage SG1 2NY (GB) |
|
| (72) |
Inventors: |
|
- ORECCHIA, Martin
Stevenage SG1 2NY (GB)
- EDWARDS, Matthew
Stevenage SG1 2NY (GB)
- BEATON, Andrew
Stevenage SG1 2NY (GB)
- HOOK, Laura
Stevenage SG1 2NY (GB)
- DIXON, David
Stevenage SG1 2NY (GB)
- GUO, Xieyang
Stevenage SG1 2NY (GB)
- CHUNG, Chun-wa
Stevenage SG1 2NY (GB)
|
| (74) |
Representative: Drury, Elizabeth Anne |
|
GSK
Legal & Compliance - Global Patents
79 New Oxford Street
London WC1A 1DG
London WC1A 1DG (GB) |
|
